Felicia Sterman, MD, MPH

NPI: 1124103353
Total Payments
$584,024
2023 Payments
$556.96
Companies
17
Transactions
1,645
Medicare Patients
484
Medicare Billing
$60,542

Payment Breakdown by Category

Other$298,531 (51.1%)
Travel$131,131 (22.5%)
Consulting$127,742 (21.9%)
Food & Beverage$26,454 (4.5%)
Education$166.67 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $298,531 160 51.1%
Travel and Lodging $131,131 281 22.5%
Consulting Fee $127,742 32 21.9%
Food and Beverage $26,454 1,153 4.5%
Education $166.67 19 0.0%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $473,202 1,001 $0 (2023)
Janssen Products, LP $50,689 62 $0 (2021)
Merck Sharp & Dohme Corporation $39,604 176 $0 (2021)
ViiV Healthcare Company $17,881 131 $0 (2021)
Janssen Biotech, Inc. $983.77 121 $0 (2021)
EMD Serono, Inc. $436.92 43 $0 (2021)
Takeda Pharmaceuticals U.S.A., Inc. $325.52 41 $0 (2019)
Bausch Health US, LLC $298.65 22 $0 (2021)
Antares Pharma, Inc. $166.75 7 $0 (2021)
Collegium Pharmaceutical, Inc. $148.71 23 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2023 $556.96 1 Gilead Sciences, Inc. ($556.96)
2021 $5,968 73 Gilead Sciences, Inc. ($4,695)
2020 $66,324 230 Gilead Sciences, Inc. ($42,158)
2019 $225,626 437 Gilead Sciences, Inc. ($181,810)
2018 $149,823 439 Gilead Sciences, Inc. ($122,080)
2017 $135,726 465 Gilead Sciences Inc ($121,903)

All Payment Transactions

1,645 individual payment records from CMS Open Payments — Page 1 of 66

Date Company Product Nature Form Amount Type
12/12/2023 Gilead Sciences, Inc. Travel and Lodging In-kind items and services $556.96 General
08/23/2021 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $17.74 General
Category: Neurology
08/23/2021 Bausch Health US, LLC APLENZIN (Drug), WELLBUTRIN Food and Beverage In-kind items and services $11.66 General
Category: Neurology
05/10/2021 Gilead Sciences, Inc. Descovy (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,960.00 General
Category: HIV
05/06/2021 Bausch Health US, LLC APLENZIN (Drug), WELLBUTRIN Food and Beverage In-kind items and services $5.58 General
Category: Neurology
04/30/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $12.43 General
04/30/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $3.57 General
04/30/2021 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $3.25 General
Category: HIV
04/28/2021 Janssen Biotech, Inc. SYMTUZA (Drug) Food and Beverage In-kind items and services $10.06 General
Category: Infectious Diseases & Vaccines
04/28/2021 Janssen Biotech, Inc. SYMTUZA (Drug) Food and Beverage In-kind items and services $5.68 General
Category: Infectious Diseases & Vaccines
04/27/2021 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $25.87 General
Category: HIV
04/26/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $3.86 General
04/23/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $23.60 General
04/22/2021 Bausch Health US, LLC APLENZIN (Drug) Food and Beverage In-kind items and services $16.88 General
Category: Neurology
04/19/2021 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $30.18 General
Category: HIV
04/19/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $4.05 General
04/16/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $15.92 General
04/14/2021 Janssen Biotech, Inc. SYMTUZA (Drug) Food and Beverage In-kind items and services $6.65 General
Category: Infectious Diseases & Vaccines
04/13/2021 Gilead Sciences, Inc. Biktarvy (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,220.00 General
Category: HIV
04/13/2021 Merck Sharp & Dohme Corporation PIFELTRO (Drug), ISENTRESS, DIFICID Food and Beverage In-kind items and services $13.48 General
Category: INFECTIOUS DISEASE
04/12/2021 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $5.39 General
Category: HIV
04/09/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $17.16 General
04/05/2021 Gilead Sciences, Inc. Food and Beverage In-kind items and services $3.70 General
03/30/2021 Merck Sharp & Dohme Corporation PIFELTRO (Drug), ISENTRESS, DIFICID Food and Beverage In-kind items and services $23.60 General
Category: INFECTIOUS DISEASE
03/29/2021 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $7.88 General
Category: HIV

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 3 135 190 $61,192 $13,465
2020 10 349 649 $177,438 $47,077
Total Patients
484
Total Services
839
Medicare Billing
$60,542
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 82 118 $36,858 $8,189 22.2%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 32 44 $18,366 $4,525 24.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 21 28 $5,968 $751.79 12.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 119 333 $104,016 $24,712 23.8%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 45 94 $39,237 $10,503 26.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 26 26 $8,806 $3,591 40.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 41 69 $14,707 $3,348 22.8%
90662 Vaccine for influenza for injection into muscle Office 2020 30 31 $1,975 $1,872 94.8%
99354 Prolonged office or other outpatient service first hour Office 2020 12 14 $5,034 $1,514 30.1%
G0008 Administration of influenza virus vaccine Office 2020 42 44 $1,760 $904.32 51.4%
90686 Vaccine for influenza for administration into muscle, 0.5 ml dosage Office 2020 12 14 $550.00 $272.26 49.5%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 11 13 $646.40 $199.14 30.8%
G0102 Prostate cancer screening; digital rectal examination Office 2020 11 11 $706.42 $160.75 22.8%

About Felicia Sterman, MD, MPH

Felicia Sterman, MD, MPH is a Internal Medicine healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124103353.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Felicia Sterman, MD, MPH has received a total of $584,024 in payments from pharmaceutical and medical device companies, with $556.96 received in 2023. These payments were reported across 1,645 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($298,531).

As a Medicare-enrolled provider, Sterman has provided services to 484 Medicare beneficiaries, totaling 839 services with total Medicare billing of $60,542. Data is available for 2 years (2020–2021), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location San Francisco, CA
  • Active Since 10/26/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1124103353

Products in Payments

  • Biktarvy (Drug) $108,093
  • Truvada (Drug) $81,428
  • Genvoya (Drug) $42,667
  • Symtuza (Drug) $28,438
  • Descovy (Drug) $19,989
  • DELSTRIGO (Drug) $16,873
  • SYMTUZA (Drug) $14,693
  • PREZCOBIX (Drug) $8,453
  • ISENTRESS (Drug) $5,942
  • TIVICAY (Drug) $4,590
  • DOVATO (Drug) $745.13
  • TRIUMEQ (Drug) $389.15
  • JULUCA (Drug) $295.41
  • APLENZIN (Drug) $257.82
  • Trintellix (Drug) $221.87
  • Serostim (Drug) $198.66
  • SEROSTIM (Biological) $175.58
  • CABENUVA (Biological) $160.94
  • UBRELVY (Drug) $129.37
  • PIFELTRO (Drug) $121.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in San Francisco